Physician profile
Jeffrey P Stewart
NPI 1053305466
$4,603.11
in general payments reported to CMS, 2019-2025
23 companies · $102 in 2025
The $102 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $304 · 2020: $406 · 2021: $732 · 2022: $1,855 · 2023: $1,048 · 2024: $157 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,305.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avinger INC. | $1,231.56 | 2022-2023 | Pantheris |
| Medtronic, INC. | $745.99 | 2021-2023 | Spiderfx |
| Abbott Laboratories | $516.54 | 2019-2025 | Jot Dx, Thoratec Heartmate 3 Lvas Implant Kit, Aveir |
| Novartis Pharmaceuticals Corporation | $332.40 | 2019-2023 | |
| Astrazeneca Pharmaceuticals Lp | $324.69 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $241.92 | 2019-2024 | Xarelto |
| Sanofi-Aventis U.S. LLC | $205.90 | 2019-2024 | |
| Pfizer INC. | $194.95 | 2019-2025 | |
| Boston Scientific Corporation | $176.92 | 2019-2023 | Lux-Dx Insertable Cardiac Monitor |
| Abiomed | $123.96 | 2019-2023 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $121.89 | 2019-2023 | Lifevest |
| Merck Sharp & Dohme LLC | $54.48 | 2021-2025 | Verquvo |
| Amgen INC. | $53.66 | 2023-2024 | Repatha |
| Novo Nordisk INC | $44.18 | 2023-2024 | Ozempic, Rybelsus |
| Baxter Healthcare | $42.42 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acist Medical Systems, INC. | $42.38 | 2022 | |
| Astellas Pharma US INC | $33.70 | 2019-2020 | |
| Silk Road Medical, INC. | $25.57 | 2021 | |
| Cashflow Solutions, LLC | $21.25 | 2023 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Lexicon Pharmaceuticals, INC. | $20.88 | 2023 | Inpefa |
| Irhythm Technologies, INC. | $17.18 | 2020 | |
| Bioventus LLC | $17.09 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $13.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Stewart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.